This is a preview of subscription content, log in via an institution to check access.
Reference
Avorn J. The $2.6 Billion Pill ? Methodologic and Policy Considerations. New England Journal of Medicine 372: 1877-1879, 14 May 2015. Available from: URL: http://dx.doi.org/10.1056/NEJMp1500848
Rights and permissions
About this article
Cite this article
$US2.6 billion cost to develop a drug questioned. PharmacoEcon Outcomes News 728, 1 (2015). https://doi.org/10.1007/s40274-015-2121-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2121-y